Hydroxychloroquine fails to protect ICU staff from coronavirus
The malaria drug doesn't reduce infection risk, reports a US trial, but a separate unpublished study finds flu vaccination might
Malaria drug hydroxychloroquine failed to protect healthcare workers caring for COVID-19 patients from becoming infected themselves, according to a US placebo-controlled trial.
The 1483 participants worked in EDs, ICUs and other high-risk sites in the US and the Canadian province of Manitoba.
